Follow
K D Steffensen
K D Steffensen
Professor, Senior Consultant, Vejle Hospital, Vejle, Denmark
Verified email at rsyd.dk
Title
Cited by
Cited by
Year
Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer
RL Coleman, GF Fleming, MF Brady, EM Swisher, KD Steffensen, ...
New England Journal of Medicine 381 (25), 2403-2415, 2019
8772019
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
AB Alvero, R Chen, HH Fu, M Montagna, PE Schwartz, T Rutherford, ...
Cell cycle 8 (1), 158-166, 2009
6202009
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients
J de Haan, M Verheecke, K Van Calsteren, B Van Calster, RG Shmakov, ...
The Lancet Oncology 19 (3), 337-346, 2018
3902018
Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting
F Amant, MJ Halaska, M Fumagalli, KD Steffensen, C Lok, ...
International Journal of Gynecologic Cancer 24 (3), 2014
3022014
Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
R Chen, AB Alvero, DA Silasi, KD Steffensen, G Mor
Oncogene 27 (2), 225-233, 2008
2772008
What works in implementing patient decision aids in routine clinical settings? A rapid realist review and update from the international patient decision aid standards collaboration
N Joseph-Williams, P Abhyankar, L Boland, P Bravo, AT Brenner, ...
Medical Decision Making 41 (7), 907-937, 2021
1462021
The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer
KD Steffensen, M Waldstrøm, I Brandslund, A Jakobsen
Gynecologic oncology 117 (1), 109-116, 2010
1392010
Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early‐stage ovarian cancer
KD Steffensen, AB Alvero, Y Yang, M Waldstrøm, P Hui, JC Holmberg, ...
Journal of oncology 2011 (1), 620523, 2011
1272011
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, ...
Annals of Oncology 33 (3), 276-287, 2022
1262022
Systematic development of patient decision aids: an update from the IPDAS collaboration
HO Witteman, KG Maki, G Vaisson, J Finderup, KB Lewis, ...
Medical Decision Making 41 (7), 736-754, 2021
1192021
The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer
KD Steffensen, M WaldstrØM, A Jakobsen
International Journal of Gynecologic Cancer 19 (5), 2009
1152009
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer …
M Gultekin, S Ak, A Ayhan, A Strojna, A Pletnev, A Fagotti, AM Perrone, ...
Cancer Medicine 10 (1), 208-219, 2021
1052021
Cancer in pregnancy: a survey of current clinical practice
SN Han, VI Kesic, K Van Calsteren, S Petkovic, F Amant, ...
European Journal of Obstetrics & Gynecology and Reproductive Biology 167 (1 …, 2013
1032013
Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
KD Steffensen, U Jeppesen, I Brandslund, A Jakobsen
International Journal of Gynecologic Cancer 18 (4), 2008
1002008
The International patient decision aid standards (IPDAS) collaboration: evidence update 2.0
D Stacey, RJ Volk, ...
Medical Decision Making 41 (7), 729-733, 2021
952021
Lessons in integrating shared decision-making into cancer care
KD Steffensen, M Vinter, D Crüger, K Dankl, A Coulter, B Stuart, LL Berry
Journal of oncology practice 14 (4), 229-235, 2018
892018
Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients
KD Steffensen, M Waldstrøm, I Brandslund, A Jakobsen
International Journal of Gynecologic Cancer 21 (6), 2011
892011
The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer
KD Steffensen, M Waldstrøm, U Jeppesen, E Jakobsen, I Brandslund, ...
International Journal of Gynecologic Cancer 17 (4), 2007
842007
Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors
K Dahl Steffensen, M Waldstrøm, R Fredslund Andersen, DA Olsen, ...
International journal of oncology 33 (1), 195-204, 2008
752008
Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature
M Verheecke, MJ Halaska, CA Lok, PB Ottevanger, R Fruscio, ...
European Journal of Cancer 50 (8), 1462-1471, 2014
732014
The system can't perform the operation now. Try again later.
Articles 1–20